A Longitudinal Observational Study of Patients with Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Primary Objective
TARGET-NASH encompasses a unique retrospective/prospective longitudinal cohort design that will define the natural history of NASH, establish important patient level baseline disease characteristics against which to judge subsequent interventions, and evaluate the safety and effectiveness of novel therapies as they are utilized in the post-marketing environment.
Details
Age
Child to Adult
Type of Study
Observational
Scope
National
Locations
University of Colorado Hospital
Principal Investigator
Amanda Wieland, MD
Study ID
Protocol Number: 17-0051
More information available at ClinicalTrials.gov: NCT02815891
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers